Preclinical Efficacy of Anti-RON Antibody-Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase. [electronic resource]
Producer: 20190723Description: 3260-3271 p. digitalISSN:- 1543-8392
- Animals
- Antibodies, Monoclonal -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Cell Line, Tumor
- Cell Survival -- drug effects
- Deoxycytidine -- analogs & derivatives
- Drug Carriers -- pharmacology
- Drug Synergism
- Female
- Fluorouracil -- pharmacology
- Humans
- Immunoconjugates -- pharmacology
- Mice
- Mice, Nude
- Oligopeptides -- pharmacology
- Oxaliplatin -- pharmacology
- Pancreatic Neoplasms -- drug therapy
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Xenograft Model Antitumor Assays
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.